Cargando…
Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19
As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic since the 1918 flu. The main challenges in mitigating COVID-19 are effective vaccination, treatment, and agile containm...
Autores principales: | Arora, Gunjan, Joshi, Jayadev, Mandal, Rahul Shubhra, Shrivastava, Nitisha, Virmani, Richa, Sethi, Tavpritesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399076/ https://www.ncbi.nlm.nih.gov/pubmed/34451513 http://dx.doi.org/10.3390/pathogens10081048 |
Ejemplares similares
-
Learning the Mental Health Impact of COVID-19 in the United States With Explainable Artificial Intelligence: Observational Study
por: Jha, Indra Prakash, et al.
Publicado: (2021) -
Identification of Ser/Thr kinase and Forkhead Associated Domains in Mycobacterium ulcerans: Characterization of Novel Association between Protein Kinase Q and MupFHA
por: Arora, Gunjan, et al.
Publicado: (2014) -
Artificial Intelligence and Antibiotic Discovery
por: David, Liliana, et al.
Publicado: (2021) -
Artificial intelligence in laser refractive surgery – Potential and promise!
por: Jayadev, Chaitra, et al.
Publicado: (2020) -
Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19
por: Mikkili, Indira, et al.
Publicado: (2021)